It occurred to me the other day that we really aren't their target market. Sounds daft, but think about it. We are fairly small in number and there are people on this forum saying Neuromod should give them to us for free to test, we'll buy one & then pass it around amongst friends, we'll buy one and then just reverse engineer our own version. Actively undermining their business basically.
Neuromod will be gearing up to try to sell this as a viable treatment to health insurers or healthcare providers. That's where they'll make their money, not through a few thousand desperate suckers like us.
It's also important to note that even though 10% of the population have tinnitus, I can assure you 10% won't be actively buying it whether that be based on price or anything else. Some people I know don't give a shit about it and won't be paying through the nose to be hooked up to a machine an hour a day. They have simply learnt to live with it happily. Yes - those people exist.
I think we are the target market. We have tinnitus and we are the ones who are preoccupied with the noise and therefore are the ones most prepared to shell out for a treatment.
There is also the topic of whether or not healthcare insurance or providers will adopt this treatment.
NICE actually reviewed Acoustic CR Neuromodulation for the NHS and it was deemed not practical and the evidence was lacking.
I can't see (as of yet) the NHS even considering this treatment. It's been tested on just over 500 people, it is still a very much experimental treatment in the medical world and relatively unheard of. It does not make business sense for a healthcare provider to adopt this treatment (yet or if ever).
Neuromod are still in the early game and their risk of bankruptcy is high, although the potential reward they may receive is also high.
If it is to be adopted by healthcare providers or insurances some factors need to be considered such as
- the cost of the treatment compared to other treatments (CBT, TRT)
- how beneficial it is to existing treatments (if Neuromod is 60% chance of success and CBT has 90% success), then why will the NHS invest in Neuromod
Also, in general, it has to be accepted that a strong evidence base is there in terms of efficacy and safety, it is stronger than any other treatments on the market, it's feasible to offer this new treatment
This is going way forward however and none of us can but speculate what it is going to happen with Neuromod.
It'll be a game changer or it will be another tested and failed method. Let's hope for the former.